Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CID-797718 is a protein kinase D1 (PKD1) inhibitor (IC50 = 7 µM).1 It also inhibits CDK activating kinase (CAK) and polo-like kinase 1 (PLK1) but has no activity at AKT (IC50s = 8.4, 21.9, and >50 µM, respectively). CID-797718 inhibits PKD1 activity in LNCaP cells with an IC50 value of 0.21 µM. CID7-97718 is a byproduct in the synthesis of CID-755673 (Item No. 15924).2
WARNING This product is not for human or veterinary use.
1. Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone. The Journal of Biological Chemisty 283(48), 33516-33526 (2008).
2. Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility. BMC Chem Biol. 10(5), (2010).